This brand name is authorized in Austria, Australia, Canada, Estonia, Finland, France, Hong Kong, Croatia, Ireland, Israel, Italy, Japan, Lithuania, Netherlands, Poland, Romania, United Kingdom, South Africa
The drug ENERZAIR contains a combination of these active pharmaceutical ingredients (APIs):
|
1
Indacaterol
UNII RYI4401DTM - INDACATEROL ACETATE
|
|
Indacaterol is a partial agonist at the human beta2-adrenergic receptor with nanomolar potency. When inhaled, indacaterol acts locally in the lung as a bronchodilator. In isolated human bronchus, indacaterol has a rapid onset of action and a long duration of action. |
|
2
Glycopyrronium bromide
UNII V92SO9WP2I - GLYCOPYRROLATE
|
|
Glycopyrronium is an inhaled long-acting muscarinic receptor antagonist (anticholinergic) for once-daily maintenance bronchodilator treatment of COPD. Glycopyrronium works by blocking the bronchoconstrictor action of acetylcholine on airway smooth muscle cells, thereby dilating the airways. |
|
3
Mometasone
UNII 04201GDN4R - MOMETASONE FUROATE
|
|
Mometasone is a topical glucocorticoid with local anti-inflammatory properties. It is likely that much of the mechanism for the effects of mometasone lies in its ability to inhibit the release of mediators of the inflammatory cascade. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| R03AL12 | R Respiratory system → R03 Drugs for obstructive airway diseases → R03A Adrenergics, inhalants → R03AL Adrenergics in combination with anticholinergics | |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: AU | Pharmaceutical Benefits Scheme | Identifier(s): 12295D, 12298G |
| Country: CA | Health Products and Food Branch | Identifier(s): 02501244 |
| Country: EE | Ravimiamet | Identifier(s): 1822014, 1822025, 1822036, 1822047, 1822058 |
| Country: FI | Lääkealan turvallisuus- ja kehittämiskeskus | Identifier(s): 398265, 498726, 580713 |
| Country: FR | Base de données publique des médicaments | Identifier(s): 61300756 |
| Country: GB | Medicines & Healthcare Products Regulatory Agency | Identifier(s): 391348, 391349 |
| Country: HK | Department of Health Drug Office | Identifier(s): 67209 |
| Country: IE | Health Products Regulatory Authority | Identifier(s): 42807, 42808 |
| Country: IL | מִשְׂרַד הַבְּרִיאוּת | Identifier(s): 9012 |
| Country: IT | Agenzia del Farmaco | Identifier(s): 048913014, 048913026, 048913038, 048913040, 048913053 |
| Country: JP | 医薬品医療機器総合機構 | Identifier(s): 2290807G1026, 2290807G2022 |
| Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1090760, 1090761, 1090762, 1090763, 1090764 |
| Country: NL | Z-Index G-Standaard, PRK | Identifier(s): 205125 |
| Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100440115 |
| Country: RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | Identifier(s): W66830001, W66830002, W66830003, W66830004, W66830005 |
| Country: ZA | Health Products Regulatory Authority | Identifier(s): 54/10.2.1/0873, 54/10.2.1/0874 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
